Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
Clinical trial NCT05852717 · RECRUITING
Trial details
- NCT number
- NCT05852717
- Sponsor
- Dipenkumar Modi
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-31
- Primary completion
- 2027-11-24
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.